Becker's Healthcare April 4, 2025
In February, Walgreens Boots Alliance entered into a $10 billion definitive agreement with private equity firm Sycamore Partners to take the company private. The total value of the deal could reach as high as $23.7 billion and is expected to close in the fourth quarter of 2025.
Under the agreement, Walgreens shareholders will receive $11.45 per share in cash at closing. They may also receive up to an additional $3 per share, depending on the future sale of Walgreens’ stakes in VillageMD, Summit Health and CityMD. Notably, Cigna’s Evernorth holds a minority stake in VillageMD.
In January, Walgreens suspended its quarterly cash dividend for the first time since 1932 to reassess its capital allocation strategy, a move tied to its...
Today's Sponsors
Today's Sponsor